Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHiscox Regulatory News (HSX)

Share Price Information for Hiscox (HSX)

Share Price is delayed by 15 minutes
Get Live Data
1,885.00    -14.00 (-0.74%)
Bid:
1,885.00
Ask:
1,886.00
Spread: 1.00 (0.053%)
Market Cap: £6.04b
HSX Live PriceLast checked at - London Stock Exchange

Intraday Hiscox Share Chart

Director/PDMR Shareholding

11 Apr 2022 14:43

RNS Number : 0012I
Hiscox Ltd
11 April 2022
 

 

Hiscox Ltd

 

(the 'Company')

 

Notification of transactions by Persons Discharging Managerial Responsibilities ('PDMR')

 

 

Hamilton, Bermuda (11 April 2021) - On 8 April 2022 awards ("Awards") were made to Executive Directors pursuant to the Company's Performance Share Plan ("Performance Share Plan"), approved by shareholders on 14 May 2020, to acquire ordinary 6.5p shares ("Shares") in the capital of the Company.

 

The Awards granted to the Executive Directors are subject to performance conditions measured over the three financial years from 1 January 2022 to 31 December 2024.

 

The performance measures for the Executive Directors will be as set out in the annual report on remuneration in the Annual Report, with 60% of the awards based on stretching growth in net asset value (NAV) plus dividends targets, measured on a per share basis, and 40% based on relative total shareholder return (TSR) against a group of global insurance peers.

 

The performance conditions for 60% of the Awards are measured against the growth in NAV plus dividends, on a per share basis, and will not vest if the growth in NAV plus dividends per share is less than the risk free rate (RFR) plus 6% per annum. 16% of the award will vest if the growth in NAV plus dividends per share is equal to the RFR plus 6% per annum, rising to 100% vesting if the growth in NAV plus dividends per share is equal to or exceeds the RFR plus 17% per annum.

 

The performance conditions for 40% of the Awards are measured against relative TSR. The relative TSR condition assesses the Company's share price and dividend performance relative to that of the comparator group of companies made up of the Company's closest listed global insurance peers over the three year performance period. 20% of the award will vest if performance is at the median, rising on a straight-line basis to 100% if the performance is in the upper quartile based on ranking.

 

Subject to the satisfaction of the performance conditions, Awards will vest on the third anniversary of their grant. The Awards granted to the Executive Directors are subject to a further two year holding period.

 

Details of the number of Shares over which Awards were granted are set out in the table below.

Executive Directors

Awards

 

HA Hussain

190,355

J Musselle

133,248

 

 

The Awards were granted from Bermuda.

 

The notifications set out below are made in accordance with the UK version of the EU Market Abuse Regulation (2014/596/EU) which is part of UK law by virtue of the European Union (Withdrawal) Act 2018.

Marc Wetherhill

 

Company Secretary

Hiscox Ltd

+ 1 441 278 8300

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBXGDSBXBDGDB
Date   Source Headline
21st Dec 20217:00 amRNSAppointment of Group Chief Financial Officer
13th Dec 20215:54 pmRNSDirector/PDMR Shareholding
6th Dec 20214:20 pmRNSTR-1:Standard form-notification major shareholding
1st Dec 20212:55 pmRNSTotal Voting Rights
22nd Nov 20219:00 amRNSHiscox appoints new Independent Non Exec Director
18th Nov 20219:00 amRNSHiscox announces Liz Breeze as interim Group CFO
2nd Nov 20217:00 amRNSTrading Statement
1st Nov 202111:12 amRNSTotal Voting Rights
7th Oct 20213:27 pmRNSPDMR Shareholding
4th Oct 20214:10 pmRNSDirector / PDMR Shareholding
1st Oct 20214:52 pmRNSTotal Voting Rights
28th Sep 20213:31 pmRNSDirector/PDMR Shareholding
22nd Sep 20213:14 pmRNSDirector/PDMR Shareholding
20th Sep 202111:40 amRNSApplication to be Admitted to Official List
16th Sep 20215:11 pmRNSDirector / PDMR Shareholding
7th Sep 20215:11 pmRNSAnnouncement of Scrip Reference Share Price
1st Sep 202112:57 pmRNSTotal Voting Rights
6th Aug 20212:50 pmRNSTR-1:Standard form - notification major holdings
5th Aug 20212:40 pmRNSTR-1:Standard form notification major shareholding
4th Aug 20214:16 pmRNSTR-1:Standard form notification of major holdings
3rd Aug 20217:01 amRNSInterim Results
3rd Aug 20217:00 amRNSSyndicates 33 and 6104 – results and estimates
2nd Aug 20211:53 pmRNSTotal Voting Rights
22nd Jul 20217:00 amRNSAki Hussain to succeed Bronek Masojada as CEO
1st Jul 202112:36 pmRNSTotal Voting Rights
30th Jun 202112:44 pmRNSTR-1 Standard form-notification major shareholding
28th Jun 20215:17 pmRNSResult of Meeting
14th Jun 20211:18 pmRNSDirector/PDMR Shareholding
7th Jun 20211:41 pmRNSTR-1:Standard form notification major shareholding
4th Jun 20212:27 pmRNSDirector/PDMR Shareholding
3rd Jun 20211:00 pmRNSDirector/PDMR Shareholding
3rd Jun 202110:30 amRNSNotice of Meeting
3rd Jun 202110:30 amRNSConsent Solicitation
3rd Jun 20217:00 amRNSLegacy Reinsurance Deal
1st Jun 202111:46 amRNSTotal Voting Rights
14th May 20217:00 amRNSAGM Results
13th May 202112:33 pmRNSSyndicates 33 and 6104 – results and estimates
5th May 20217:00 amRNSTrading Statement
20th Apr 202111:51 amRNSDirector/PDMR Shareholding
16th Apr 202112:47 pmRNSDirector/PDMR Shareholding
13th Apr 202111:41 amRNSNotice of 2021 Annual General Meeting
12th Apr 20212:57 pmRNSDirector/PDMR Shareholding
1st Apr 20213:55 pmRNSTotal Voting Rights
24th Mar 20217:00 amRNSDirector/PDMR Shareholding
22nd Mar 202112:49 pmRNSDirector/PDMR Shareholding
17th Mar 20217:00 amRNS2020 Annual Report
15th Mar 20216:28 pmRNSDirector/PDMR Shareholding
15th Mar 20216:13 pmRNSDirector/PDMR Shareholding
11th Mar 20217:00 amRNSTR-1:Standard form-notification major shareholding
3rd Mar 20217:01 amRNSFull Year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.